Achieve Life Sciences investor relations material

Achieve Life Sciences Inc. is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel small molecules for treating diseases with high unmet need. Cytisinicline is our next-generation smoking cessation treatment; it has been developed to address many of the known causes of relapse associated with quitting smoking, including short-term nicotine withdrawal symptoms and long-term craving for cigarettes.